AVAL
Grupo Aval Acciones Y Valores S.A.
$5.55
+3.16%
$6.6B
No data for this timeframe.
Vol
Market Cap$6.6B
Cap SizeMid Cap
Inst. Holders12 funds
Inst. Value$6.1M
Inst. Activity2 buys / 1 sells
SEC Reports6
Recent Activity
Jun 10, 2026
SEC
Grupo Aval and its bank subsidiaries transferred their 52.80% stake in Corficolombiana to Ficentro (a Panamanian affilia
6-K — Impact 2/10
Apr 20, 2026
SEC
Grupo Aval Acciones y Valores S.A. announced the filing of its annual Form 20-F for the year ended December 31, 2025, wi
6-K — Impact 2/10
Apr 16, 2026
SEC
Citigroup initiated coverage with a double upgrade to Buy from Neutral on October 20, 2025, despite no price target. The
ANALYST-UPGRADE — Impact 6/10
Inst.
MARSHALL WACE, LLP — TRIM
137,326 shares ($604.2K)
Inst.
Connor, Clark & Lunn — ADD
72,612 shares ($319.5K)
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$4.00 (Jan 2026)
Current $5.55
Low $4.00
Median $4.00
High $4.00
1 analysts
$4.00
$4.00
Analyst Ratings
0Strong Buy
0Buy
5Hold
2Sell
1Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 22, 2026 | Citigroup | DOWNGRADE | Buy → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.12 | $0.12 — $0.12 | 18% YoY | 1 |
| Next Q | $0.13 | $0.13 — $0.13 | 6% YoY | 1 |
| Current FY | $0.42 ▼ -8.8% | $0.42 — $0.42 | 251% YoY | 1 |
| Next FY | $0.56 ▲ +3.3% | $0.53 — $0.58 | 33% YoY | 2 |
Latest Reports
NEUTRAL
6-K
2/10
Grupo Aval and its bank subsidiaries transferred their 52.80% stake in Corficolombiana to Ficentro (a Panamanian affilia
Jun 10, 2026
MIXED
ANALYST-UPGRADE
6/10
Citigroup initiated coverage with a double upgrade to Buy from Neutral on October 20, 2025, despite no price target. The
Apr 16, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $3.9M | — |
| MARSHALL WACE, LLP | $604.2K | TRIM |
| DIMENSIONAL FUND ADVISORS LP | $580.3K | ADD |
| BlackRock, Inc. | $470.4K | ADD |
| Connor, Clark & Lunn | $319.5K | ADD |
12 institutional holders with $6.1M total value (1,383,825 shares) as of 2026-Q1. Top holders: RENAISSANCE, MARSHALL, DIMENSIONAL. Net buying activity: 2 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 895,772 | $3.9M | 64.8% | — |
| 2 | MARSHALL WACE, LLP | 137,326 | $604.2K | 9.9% | TRIM -50.1% |
| 3 | DIMENSIONAL FUND ADVISORS LP | 132,619 | $580.3K | 9.5% | ADD +34.7% |
| 4 | BlackRock, Inc. | 106,901 | $470.4K | 7.7% | ADD +30.4% |
| 5 | Connor, Clark & Lunn Investment Management Ltd. | 72,612 | $319.5K | 5.2% | ADD +63.5% |
| 6 | National Philanthropic Trust | 17,986 | $79.1K | 1.3% | — |
| 7 | MORGAN STANLEY | 10,096 | $44.4K | 0.7% | DOUBLED +452.6% |
| 8 | ASSETMARK, INC | 4,534 | $19.9K | 0.3% | DOUBLED +1837.6% |
| 9 | RHUMBLINE ADVISERS | 3,288 | $14.5K | 0.2% | TRIM -56.8% |
| 10 | WELLS FARGO & COMPANY/MN | 2,500 | $11.0K | 0.2% | — |
| 11 | Allworth Financial LP | 159 | $700.00 | 0.0% | NEAR_EXIT -78.6% |
| 12 | NISA INVESTMENT ADVISORS, LLC | 32 | $141.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | TRIM | 275,148 | 137,326 | -50.1% | $604.2K | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 44,412 | 72,612 | +63.5% | $319.5K | 2026-Q1 |
| ASSETMARK, INC | DOUBLED | 234 | 4,534 | +1837.6% | $19.9K | 2026-Q1 |
| MARSHALL WACE, LLP | DOUBLED | 35,120 | 275,148 | +683.5% | $1.1M | 2025-Q4 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 29,709 | 44,412 | +49.5% | $179.9K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 284 | 3 | -98.9% | $12.00 | 2025-Q4 |
| DIMENSIONAL FUND ADVISORS LP | ADD | 103,311 | 139,173 | +34.7% | $458.5K | 2025-Q3 |
| MARSHALL WACE, LLP | TRIM | 60,733 | 35,120 | -42.2% | $115.9K | 2025-Q3 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 21,049 | 29,709 | +41.1% | $98.0K | 2025-Q3 |
| RHUMBLINE ADVISERS | TRIM | 7,618 | 3,288 | -56.8% | $10.8K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 456 | 284 | -37.7% | $937.00 | 2025-Q3 |
| Allworth Financial LP | NEAR_EXIT | 744 | 159 | -78.6% | $525.00 | 2025-Q3 |
| DIMENSIONAL FUND ADVISORS LP | ADD | 72,667 | 103,311 | +42.2% | $290.5K | 2025-Q2 |
| MARSHALL WACE, LLP | ADD | 34,980 | 60,733 | +73.6% | $170.7K | 2025-Q2 |
| Connor, Clark & Lunn Investment Management Ltd. | ADD | 12,455 | 21,049 | +69.0% | $59.1K | 2025-Q2 |
| RHUMBLINE ADVISERS | DOUBLED | 3,288 | 7,618 | +131.7% | $21.4K | 2025-Q2 |
| BlackRock, Inc. | ADD | 63,023 | 82,206 | +30.4% | $224.4K | 2025-Q1 |
| UBS Group AG | ADD | 106,160 | 167,661 | +57.9% | $340.4K | 2024-Q4 |
| Mariner, LLC | NEAR_EXIT | 194,837 | 16,394 | -91.6% | $33.3K | 2024-Q3 |
| Vident Advisory, LLC | TRIM | 14,586 | 10,619 | -27.2% | $21.6K | 2024-Q3 |
| MORGAN STANLEY | DOUBLED | 1,124 | 6,211 | +452.6% | $12.6K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 5 neutral. Avg impact: 3.3/10.
MIXED
ANALYST-UPGRADE
6/10
Citigroup initiated coverage with a double upgrade to Buy from Neutral on October 20, 2025, despite
Apr 16, 2026
NEUTRAL
6-K
2/10
Grupo Aval and its bank subsidiaries transferred their 52.80% stake in Corficolombiana to Ficentro (
Jun 10, 2026
NEUTRAL
6-K
2/10
Grupo Aval Acciones y Valores S.A. announced the filing of its annual Form 20-F for the year ended D
Apr 20, 2026
NEUTRAL
6-K
3/10
Grupo Aval Acciones y Valores S.A. confirmed the payment of dividends in April 2026, as approved by
Apr 7, 2026
NEUTRAL
6-K
2/10
Grupo Aval Acciones y Valores S.A. announced the payment of interest on its Sixth Issuance of Notes
Mar 31, 2026
NEUTRAL
6-K
5/10
Grupo Aval's 2026 shareholder meeting approved the distribution of $2.65 per share per month in divi
Mar 30, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 0% buy across 8 analysts — 0 strong buy, 0 buy, 5 hold, 2 sell, 1 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$4.00 mean target (Jan 2026)
$4.00 Low
$4.00 High
| Metric | Value |
|---|---|
| Current Price | $5.55 |
| Target Low | $4.00 |
| Target Mean | $4.00 |
| Target Median | $4.00 |
| Target High | $4.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.12 | $0.12 | $0.12 | 18.1% | — | — | $4736.4B | 6.6% | 1 |
| Next Q 2026-09-30 |
$0.13 | $0.13 | $0.13 | 6.1% | — | — | $4785.0B | 6.6% | 1 |
| Current FY 2026-12-31 |
$0.42 | $0.42 | $0.42 | 250.6% | -8.8% | — | $19387.0B | 10.9% | 1 |
| Next FY 2027-12-31 |
$0.56 | $0.53 | $0.58 | 32.6% | +3.3% | 1↑ 0↓ | $21664.4B | 11.8% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.122 | |
| 7d ago | $0.000 | +0.122 |
| 30d ago | $0.000 | +0.122 |
| 60d ago | $0.000 | +0.122 |
| 90d ago | $0.000 | +0.122 |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 22, 2026 | Citigroup | DOWNGRADE | Buy | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 5 | 2 | 1 | 0% | |
| May 1, 2026 | 0 | 0 | 5 | 1 | 1 | 0% | |
| Apr 1, 2026 | 0 | 0 | 5 | 1 | 1 | 0% | |
| Mar 1, 2026 | 0 | 0 | 4 | 1 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 4 | 1 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 4 | 1 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.